|
1) Kohchi K, Takebayashi S, Hiroki T, et al. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation. 1985; 71: 709-16
|
|
|
|
2) Valent P. Cytokines involved in growth and differentiation of human basophils and mast cells. Exp Dermatol. 1995; 4: 255-9
|
|
|
|
|
3) Valent P, Sillaber C, Bettelheim P. The growth and differentiation of mast cells. Prog Growth Factor Res. 1991; 3: 27-41
|
|
|
|
|
|
4) Puxeddu I, Piliponsky AM, Bachelet I, et al. Mast cells in allergy and beyond. Int J Biochem Cell Biol. 2003; 35: 1601-7
|
|
|
|
|
|
5) Kaartinen M, Penttila A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 1994; 90: 1669-78
|
|
|
|
|
|
6) Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol. 1997; 182: 115-22
|
|
|
|
|
|
7) Laine P, Kaartinen M, Penttila A, et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999; 99: 361-9
|
|
|
|
|
|
8) Libby P, Shi GP. Mast cells as mediators and modulators of atherogenesis. Circulation. 2007; 115: 2471-3
|
|
|
|
|
|
9) Zudaire E, Martinez A, Garayoa M, et al. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol. 2006; 168: 280-91
|
|
|
|
|
|
10) Bot I, de Jager SC, Zernecke A, et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation. 2007; 115: 2516-25
|
|
|
|
|
|
11) Heikkila HM, Latti S, Leskinen MJ, et al. Activated mast cells induce endothelial cell apoptosis by a combined action of chymase and tumor necrosis factor-α. Arterioscler Thromb Vasc Biol. 2008; 28: 309-14
|
|
|
|
|
|
12) Leskinen MJ, Heikkila HM, Speer MY, et al. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-κB-mediated survival signaling. Exp Cell Res. 2006; 312: 1289-98
|
|
|
|
|
|
13) Sun J, Sukhova GK, Wolters PJ, et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med. 2007; 13: 719-24
|
|
|
|
|
|
14) Hallett J. W. J. Management of abdominal aortic aneurysms. Mayo Clin Proc. 2000; 75: 395-9
|
|
|
|
|
|
15) Sun J, Sukhova GK, Yang M, et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest. 2007; 117: 3359-68
|
|
|
|
|
|
16) Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004; 24: 429-34
|
|
|
|
|
|
17) Xiong W, Zhao Y, Prall A, et al. Key roles of CD4＋ T cells and IFN-γ in the development of abdominal aortic aneurysms in a murine model. J Immunol. 2004; 172: 2607-12
|
|
|
|
|
|
18) Longo GM, Xiong W, Greiner TC, et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002; 110: 625-32
|
|
|
|
|
|
19) Tsuruda T, Kato J, Hatakeyama K, et al. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res. 2008; 102: 1368-77
|
|
|
|
|